ESAB: Good Execution, Strength In Emerging Markets And Accretive M&A Make Me Bullish
ESAB's net sales saw ~2% decline in Q2 2024 due to weak markets. Organic sales grew ~1% Y/Y, driven by equipment and automation. Emerging markets are growing twice as fast, contributing to ESAB's strategy. Focus on M&A and product innovation will support long-term revenue growth. ESAB's stock trades at a discount relative to peers, indicating potential upside.
View signal analysis